News and Announcements
MedAdvisor Signs MoU with Glaucoma Australia Partnership to Assist 300,000 Australians
- Published August 15, 2016 2:37PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
15th August 2016, ASX Announcement
Highlights
- MedAdvisor has signed a Memorandum of Understanding with Glaucoma Australia, the leading not-for-profit patient support organisation for people living with glaucoma
- Glaucoma Australia will become a MedAdvisor Health Association Partner and promote the MedAdvisor platform to more than 300,000 Australians estimated to have glaucoma
- Builds on MedAdvisor’s growing Health Partner network, providing strong third party validation and support from recognised health association bodies
MedAdvisor Limited (ASX: MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has signed a Memorandum of Understanding (MoU) with Glaucoma Australia Inc, to help improve medication adherence in patients living with glaucoma.
Glaucoma Australia is the peak not-for-profit patient support organisation for people living with Glaucoma in Australia.
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
